ReviewProceedings of the Japan Academy. Series B, Physical and biological sciences2018

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy.

Tsukasa Seya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.